Indoco Remedies Share Price
Small Cap | Pharmaceuticals and health care | NSE: INDOCO | BSE: 532612
₹341.30 
6.15 (1.83 %)
Last Updated: 21 Jan 2025 04:01 PM
BEARISH
Overview
Open (₹) 341.55
High (₹) 348.00
Low (₹) 320.45
Prev. Close (₹) 335.15
Volume 24,973
VWAP (₹) 335.85
ROCE (%) 10.59
Industry P/E 47.32
TTM P/E 98.07
P/B Ratio 2.83
Market Cap (₹) Cr.3,059.07
Dividend Yield (%)0.44
EPS (₹) 10.51
ROE8.72%
Sales Growth (%) 8.91
Profit Growth (%)-31.81
Day Range
320.45348.00
52 Week Range
286.50414.35
Historical Returns
Returns (6M)
5.49 %
Returns (1Y)
-7.53 %
Returns (3Y)
-14.58 %
Returns (5Y)
53.5 %
Returns (6M)
5.49 %
Returns (1Y)
-7.53 %
Returns (3Y)
-14.58 %
Returns (5Y)
53.5 %
SWOT Analysis
Stock Price Chart
Technicals
Technical Rating
BEARISHRSI 54.88
MFI 83.58
ATR 9.66
Commodity Channel Index 87.73
ROC125 4.45
ROC21 1.05
Williams %R -20.29
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 353.41 | 364.48 | 380.96 | 336.93 | 325.86 | 309.38 | 298.31 |
| Week Ago | 338.16 | 339.93 | 341.91 | 336.18 | 334.41 | 332.43 | 330.66 |
| Month Ago | 345.84 | 352.52 | 360.44 | 337.92 | 331.24 | 323.32 | 316.64 |
EMA & SMA
341.30
Current Price
Bullish Moving Averages
20
Bearish Moving Averages
0
5 Day 329.49
9 Day 332.45
10 Day 332.10
12 Day 332.46
14 Day 332.97
20 Day 333.16
26 Day 333.91
50 Day 325.05
100 Day 337.16
200 Day 332.98
Volume Analysis
| Date | Volume | Delivery (%) |
|---|---|---|
| 21 Jan, 2025 | 8,71,078 | 40.76 |
| 20 Jan, 2025 | 34,141 | 70.12 |
| 17 Jan, 2025 | 57,304 | 47.70 |
| 16 Jan, 2025 | 38,709 | 81.31 |
| 15 Jan, 2025 | 21,090 | 59.45 |
| 14 Jan, 2025 | 30,011 | 72.14 |
| 08 Jan, 2025 | 51,405 | 55.67 |
Financials
Deals & Announcements
Bulk and Block Deals
Insider Trading
| Date | Name | Action | Avg, Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 27 Nov, 2024 | ADITI PANANDIKAR | Acquisition | ₹302.4000242954324586977648202 | 8,232 | BSE |
| 21 Nov, 2024 | ADITI PANANDIKAR | Acquisition | ₹303.5042961004626569729015202 | 15,130 | BSE |
| 19 Nov, 2024 | ADITI PANANDIKAR | Acquisition | ₹304.00 | 3,000 | BSE |
| 19 Nov, 2024 | ADITI PANANDIKAR | Acquisition | ₹305.00 | 2,220 | BSE |
| 13 Nov, 2024 | ADITI PANANDIKAR | Acquisition | ₹304.00 | 651 | BSE |
| 12 Nov, 2024 | ADITI PANANDIKAR | Acquisition | ₹306.00 | 10,400 | BSE |
| 12 Nov, 2024 | ADITI PANANDIKAR | Acquisition | ₹306.00 | 612 | BSE |
| 05 Jun, 2024 | MADHURA SURESH KARE | Acquisition | ₹300.00 | 4,000 | BSE |
| 05 Jun, 2024 | ADITI MILIND PANANDIKAR | Acquisition | ₹295.55 | 7,300 | BSE |
| 04 Jun, 2024 | MADHURA S KARE | Acquisition | ₹302.50 | 6,000 | BSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 16 May, 2024 | Rs.1.5000 per share(75%)Final Dividend | 19 Sept, 2024 | 01 Jan, 1970 |
| 23 May, 2023 | Rs.2.2500 per share(112.5%)Final Dividend | 18 Sept, 2023 | 01 Jan, 1970 |
| 18 May, 2022 | Rs.0.7500 per share(37.5%)Special Dividend | 14 Sept, 2022 | 01 Jan, 1970 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 21 Jan, 2025 | BSE India | Pursuant to the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, the audio recording of the earnings conference call in respect of Unaudited Standalone and Consolidated Financial Results for the Quarter and nine months ended 31st December, 2024 held today i.e. 21st January, 2025 at 03:30 p.m. (IST) is available on the Company's website at https://www.indoco.com/inv-fin-concall-transcripts.asp. The Earnings Conference Call concluded at 04.20 p.m. (IST) on 21st January, 2025.\r\n\r\n |
| 21 Jan, 2025 | BSE India | Integrated Financials for the quarter and nine months ended 31st December, 2024 |
| 21 Jan, 2025 | BSE India | Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December, 2024 |
| 21 Jan, 2025 | BSE India | Pursuant to the Regulation 30 read with Schedule III and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. 21st January, 2025 has inter-alia considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December, 2024 along with the Limited Review Report with unmodified opinion on the aforesaid Unaudited Financial Results. |
| 21 Jan, 2025 | BSE India | Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, this is to inform you that the Nomination and Remuneration Committee in its meeting held today i.e. 21st January, 2025 has approved the allotment of 65,700 equity shares of face value of Rs. 2 each to the Indoco Employees Welfare Trust under Indoco Remedies Limited Employee Stock Option Plan-2022. |
| 15 Jan, 2025 | NSE India | Indoco Remedies Limited has informed the Exchange about Schedule of meet |
| 15 Jan, 2025 | BSE India | We wish to inform you that an Earnings Conference Call on unaudited financial results for the quarter and nine months ended 31-12-2024 is scheduled to be held on Tuesday,21st January 2025 at 03:30 P.M. IST. |
| 15 Jan, 2025 | NSE India | Indoco Remedies Limited has informed the Exchange about Schedule of meet |
| 15 Jan, 2025 | BSE India | We wish to inform you that an Earnings Conference Call on unaudited financial results for the quarter and nine months ended 31-12-2024 is scheduled to be held on Tuesday, 21st January,2025 at 03:30 pm IST. |
| 13 Jan, 2025 | NSE India | INDOCO REMEDIES LIMITED has informed the Exchange about Board Meeting to be held on 21-Jan-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 . |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 14 Jan, 2025 | 21 Jan, 2025 |
| Quarterly Results | -- | 15 Oct, 2024 | 24 Oct, 2024 |
| Quarterly Results | -- | 11 Jul, 2024 | 23 Jul, 2024 |
| Audited Results & Final Dividend | -- | 10 May, 2024 | 16 May, 2024 |
| Quarterly Results | -- | 11 Jan, 2024 | 23 Jan, 2024 |
| Quarterly Results | -- | 10 Oct, 2023 | 19 Oct, 2023 |
| Quarterly Results | -- | 18 Jul, 2023 | 25 Jul, 2023 |
| Audited Results & Final Dividend | -- | 15 May, 2023 | 23 May, 2023 |
| Quarterly Results | -- | 12 Jan, 2023 | 24 Jan, 2023 |
| Quarterly Results | -- | 24 Oct, 2022 | 10 Nov, 2022 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About Indoco Remedies
Indoco Remedies is a Public Limited Listed company incorporated on 23/08/1947 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L85190MH1947PLC005913 and registration number is 005913. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 1790.81 Cr. and Equity Capital is Rs. 18.44 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1947
Managing Director
Ms. Aditi Panandikar
NSE Symbol
INDOCO
Indoco Remedies Management
| Name | Designation |
|---|---|
| Mr. Suresh G Kare | Chairman |
| Ms. Aditi Panandikar | Managing Director |
| Mr. Sundeep V Bambolkar | Joint Managing Director |
| Dr. Anand Nadkarni | Non Executive Director |
| Mr. Satish Shenoy | Independent Director |
| Mr. Ajay Mulgaokar | Independent Director |
| Dr.(Ms.) Vasudha V Kamat | Independent Director |
| Mr. Abhijit Y Gore | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| SunPhrmInds | ₹4,46,576.22 | ₹1,762.70  ₹1,778.25(-0.87%) | ₹1,249.800 - ₹1,960.200 |
| Divis Labora | ₹1,56,123.40 | ₹5,818.90 ₹6,000.60(-3.03%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,21,675.13 | ₹1,428.00 ₹1,445.45(-1.21%) | ₹1,240.700 - ₹1,702.000 |
| ManKind Phar | ₹1,18,478.90 | ₹2,563.55 ₹2,704.70(-5.22%) | ₹1,910.100 - ₹3,050.000 |
| DrReddysLab | ₹1,15,939.04 | ₹1,288.15 ₹1,302.35(-1.09%) | ₹1,104.690 - ₹1,420.200 |
FAQs on Indoco Remedies
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)